These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29895033)
1. Metabolic Syndrome in Hypopituitarism. Miljić D; Popovic V Front Horm Res; 2018; 49():1-19. PubMed ID: 29895033 [TBL] [Abstract][Full Text] [Related]
2. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. Filipsson H; Monson JP; Koltowska-Häggström M; Mattsson A; Johannsson G J Clin Endocrinol Metab; 2006 Oct; 91(10):3954-61. PubMed ID: 16895963 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P; J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle. Stewart PM; Toogood AA; Tomlinson JW Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677 [TBL] [Abstract][Full Text] [Related]
5. Visceral fat measurement by ultrasound as a non-invasive method - can it be useful in evaluating subclinical atherosclerosis in male patients with hypopituitarism and growth hormone deficiency? Topaloglu O; Gokay F; Koparal SS; Akbaba G; Mete T; Arduc A; Tuna MM; Yalcin Y; Yavuz HC; Berker D; Guler S Endokrynol Pol; 2014; 65(3):195-202. PubMed ID: 24971920 [TBL] [Abstract][Full Text] [Related]
6. Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism. Mazziotti G; Mormando M; Cristiano A; Bianchi A; Porcelli T; Giampietro A; Maffezzoni F; Serra V; De Marinis L; Giustina A Eur J Endocrinol; 2014 Jun; 170(6):893-9. PubMed ID: 24836549 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study. Bhat MA; Laway BA; Shah ZA; Wani AI; Mubarik I Pituitary; 2015 Jun; 18(3):312-8. PubMed ID: 24879499 [TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and its components in adult hypopituitary patients. Abe SY; Dos Santos KS; Barbosa BFB; Biondo CMP; Takito D; Hayashi SK; Amarilla VGV; Ulbrich AZ; Boguszewski CL Pituitary; 2020 Aug; 23(4):409-416. PubMed ID: 32418172 [TBL] [Abstract][Full Text] [Related]
10. Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or levothyroxine. Nishioka H; Haraoka J J Endocrinol Invest; 2005 Jun; 28(6):528-33. PubMed ID: 16117194 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Dunne FP; Elliot P; Gammage MD; Stallard T; Ryan T; Sheppard MC; Stewart PM Clin Endocrinol (Oxf); 1995 Nov; 43(5):623-9. PubMed ID: 8548948 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Verhelst J; Mattsson AF; Luger A; Thunander M; Góth MI; Koltowska-Häggström M; Abs R Eur J Endocrinol; 2011 Dec; 165(6):881-9. PubMed ID: 21969523 [TBL] [Abstract][Full Text] [Related]
13. [Unfavourable cardiovascular consequences of adult growth hormone deficiency]. Ratku B; Sebestyén V; Szelesné Árokszállási A; Erdei A; Berta E; Szabó Z; Bodor M; Nagy VE; Somodi S Orv Hetil; 2023 Oct; 164(41):1616-1627. PubMed ID: 37987695 [TBL] [Abstract][Full Text] [Related]
14. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804 [TBL] [Abstract][Full Text] [Related]
15. Special features on insulin resistance, metabolic syndrome and vascular complications in hypopituitary patients. Garmes HM Rev Endocr Metab Disord; 2024 Jun; 25(3):489-504. PubMed ID: 38270844 [TBL] [Abstract][Full Text] [Related]
16. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy. O'Neal DN; Hew FL; Best JD; Alford F Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452 [TBL] [Abstract][Full Text] [Related]